Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Catalyst Pharmaceutical Partners, Inc. (CPRX)  
$15.94 0.33 (2.03%) as of 4:30 Thu 3/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 103,650,000
Market Cap: 1.65(B)
Last Volume: 1,172,260 Avg Vol: 1,697,852
52 Week Range: $11.5 - $18.08
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:

    NASDAQ COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  604
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 254,000 458,367 4,173,516
Total Sell Value $0 $3,535,050 $6,851,624 $61,846,148
Total People Sold 0 5 7 12
Total Sell Transactions 0 6 11 51
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 312
  Page 1 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2024-03-27 4 S $16.44 $411,000 D/D (25,000) 124,433     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2024-02-15 4 D $0.00 $0 D/D (2,353) 149,433     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 9,667 151,786     -
   O'keeffe Charles B Director   –       •      –    2024-02-15 4 OE $0.00 $0 D/D 4,000 685,724     -
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2024-02-15 4 D $0.00 $0 D/D (3,125) 25,968     -
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 10,667 29,093     -
   Sundaram Preethi Chief Strategy Officer   •       –      –    2024-02-15 4 D $0.00 $0 D/D (6,025) 25,541     -
   Sundaram Preethi Chief Strategy Officer   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 16,667 31,566     -
   Tierney David S Director   –       •      –    2024-02-15 4 OE $0.00 $0 D/D 4,000 348,874     -
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2024-02-15 4 D $0.00 $0 D/D (2,435) 51,391     -
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 10,000 53,826     -
   Miller Steve Chief Op. & Scientific Officer   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 13,667 825,124     -
   Harper Molly Director   –       •      –    2024-02-15 4 OE $0.00 $0 D/D 4,000 5,333     -
   Daly Richard J President and CEO   •       •      –    2024-02-15 4 D $0.00 $0 D/D (1,186) 212,147     -
   Daly Richard J President and CEO   •       •      –    2024-02-15 4 OE $0.00 $0 D/D 4,000 213,333     -
   Denkhaus Donald A Director   –       •      –    2024-02-15 4 OE $0.00 $0 D/D 4,000 438,333     -
   Denkhaus Donald A Director   –       •      –    2024-02-05 4 OE $4.01 $160,400 D/D 40,000 434,333     -
   Mcenany Patrick J Chairman of Board of Directors   –       •      –    2024-01-30 4 OE $0.00 $0 D/D 143,000 4,528,256     -
   Tierney David S Director   –       •      –    2024-01-02 4 OE $1.13 $11,300 D/D 10,000 344,874     -
   O'keeffe Charles B Director   –       •      –    2024-01-02 4 OE $1.13 $67,800 D/D 60,000 681,724     -
   Mcenany Patrick J Chairman of Board of Directors   –       •      –    2024-01-02 4 OE $1.13 $282,500 D/D 250,000 4,385,256     -
   Denkhaus Donald A Director   –       •      –    2023-12-27 4 OE $0.00 $0 D/D 1,333 394,333     -
   Sundaram Preethi Chief Strategy Officer   •       –      –    2023-12-27 4 D $0.00 $0 D/D (2,409) 14,899     -
   Sundaram Preethi Chief Strategy Officer   •       –      –    2023-12-27 4 OE $0.00 $0 D/D 6,666 17,308     -
   Harper Molly Director   –       •      –    2023-12-27 4 OE $0.00 $0 D/D 1,333 1,333     -

  312 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed